Rocket Pharmaceuticals, Inc. Common Stock Share Price
NASDAQ: RCKTHealthcare
Live Rocket Pharmaceuticals, Inc. Common Stock Share Price Chart
O H L
Rocket Pharmaceuticals, Inc. Common Stock Performance Overview
Days Range
▼
$3.44Low
$3.56High
Markets Today
| Previous Close | $3.50 |
|---|---|
| Open | $3.49 |
| Volume | 304,861 |
| Day's Range | $3.44 - $3.56 |
| 52W Range | $2.53 - $5.45 |
| Market Cap | $382.02 M |
Historical Performance
| 1M Returns | +4.79 |
|---|---|
| 3M Returns | +4.48 |
| 6M Returns | -21.70 |
| 1Y Returns | +10.41 |
| 5Y Returns | -89.77 |
| 10Y Returns | NA |
Rocket Pharmaceuticals, Inc. Common Stock Fundamentals
| Market Cap | $382.02 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.60 |
| EPS TTM | $-0.18 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.03 |
| EBITDA | $-219.65 M |
| Profit Margin | N/A |
| Market Cap | $382.02 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.60 |
| EPS TTM | $-0.18 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.03 |
| EBITDA | $-219.65 M |
| Profit Margin | N/A |
Rocket Pharmaceuticals, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$64.39 M | -$71.15 M | -$52.25 M | -$43.96 M | -$48.51 M | -$46.92 M |
| EBITDA | -$61.94 M | -$65.64 M | -$49.72 M | -$42.35 M | -$46.90 M | -$45.36 M |
| Interest Expense | -$472.00 K | -$473.00 K | -$473.00 K | -$473.00 K | -$473.00 K | -$473.00 K |
| Depreciation | $2.45 M | $5.51 M | $2.53 M | $1.61 M | $1.61 M | $1.56 M |
| Income Before Tax | -$63.52 M | -$68.92 M | -$50.33 M | -$42.54 M | -$48.82 M | $131.84 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $8.62 M |
| Net Income + | -$63.52 M | -$68.92 M | -$50.33 M | -$42.54 M | -$48.82 M | $123.21 M |
| Net Profit Margin | - | - | - | - | - | - |
Rocket Pharmaceuticals, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $1.07 M | $1.08 M | $1.08 M | $1.08 M | $1.09 M | $1.09 M |
| Reserve & Surplus | -$1.28 B | -$1.35 B | -$1.40 B | -$1.44 B | -$1.49 B | -$1.37 B |
| Non-Current Liabilities | $23.62 M | $23.37 M | $23.19 M | $23.02 M | $22.90 M | $22.95 M |
| Current Liabilities | $35.31 M | $43.40 M | $31.17 M | $30.21 M | $24.47 M | $31.32 M |
| Total Liabilities | $58.93 M | $66.77 M | $54.36 M | $53.23 M | $47.37 M | $54.27 M |
| Fixed Assets | $59.72 M | $57.67 M | $54.92 M | $53.32 M | $51.80 M | $50.25 M |
| Current Assets | $324.49 M | $277.15 M | $227.68 M | $192.73 M | $149.83 M | $289.55 M |
| Total Assets | $471.07 M | $420.98 M | $368.03 M | $330.45 M | $285.41 M | $423.10 M |
Rocket Pharmaceuticals, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$61.33 M | -$68.92 M | -$50.33 M | -$42.54 M | -$47.59 M | $123.21 M |
| Operating Cash Flow | -$55.79 M | -$48.96 M | -$50.42 M | -$34.84 M | -$45.39 M | -$39.61 M |
| Investing Cash Flow | -$58.03 M | $31.76 M | $93.62 M | $36.42 M | $17.45 M | $214.36 M |
| Financing Cash Flow | $0 | $215.00 K | -$67.00 K | $0 | -$1.00 K | $150.00 K |
| Change in Cash | -$113.83 M | -$16.99 M | $43.13 M | $1.58 M | -$27.95 M | $174.90 M |
Rocket Pharmaceuticals, Inc. Common Stock Return Calculator
The Rocket Pharmaceuticals, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,006
Invested Amount$10,000
Est. Returns$-8,994
About Rocket Pharmaceuticals, Inc. Common Stock
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Popular Stocks
FAQs
What is the share price of Rocket Pharmaceuticals, Inc. Common Stock today?
Rocket Pharmaceuticals, Inc. Common Stock (RCKT) share price as of September 18, 2026 is $3.44. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Rocket Pharmaceuticals, Inc. Common Stock?
Yes, Indian Investors can invest in the Rocket Pharmaceuticals, Inc. Common Stock (RCKT) Share by opening an international trading account with Angel One.
How can I purchase Rocket Pharmaceuticals, Inc. Common Stock shares in India?
Purchasing Rocket Pharmaceuticals, Inc. Common Stock (RCKT) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Rocket Pharmaceuticals, Inc. Common Stock (RCKT) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Rocket Pharmaceuticals, Inc. Common Stock?
Yes, you can purchase fractional shares of Rocket Pharmaceuticals, Inc. Common Stock (RCKT) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Rocket Pharmaceuticals, Inc. Common Stock?
The market capitalization of Rocket Pharmaceuticals, Inc. Common Stock on September 18, 2026, is $382.02 M.
In which sector Rocket Pharmaceuticals, Inc. Common Stock belongs?
Rocket Pharmaceuticals, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Rocket Pharmaceuticals, Inc. Common Stock stocks?
In order to invest in Rocket Pharmaceuticals, Inc. Common Stock (RCKT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
